News
Captopril questioned for diabetes patients in COVID-19 setting
July 2, 2020
Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers, a new study suggests.
![1]()
News
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
June 26, 2020
The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early speculation, diuresis may be off the list.
![1]()
News
ED visits for life-threatening conditions declined early in COVID-19 pandemic
June 23, 2020
Visits for MI, stroke, and hypoglycemic crisis dropped 10%-23% over the first 10 weeks.
![1]()
News
Cost of preventable adult hospital stays topped $33 billion in 2017
June 23, 2020
Heart failure, diabetes, and COPD were the most expensive preventable conditions.
News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
June 22, 2020
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.
![1]()
News
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
June 16, 2020
In the landmark DAPA-HF trial that enrolled HFrEF patients without diabetes, treatment with dapagliflozin cut incident type 2 diabetes by a relative 32%.
![1]()
News
For COVID-19 plus diabetes, glycemic control tops treatment list
June 15, 2020
Tight glucose control led to better results in patients with diabetes and COVID-19.
News
Half of type 1 diabetes patients with COVID-19 manage at home
June 12, 2020
Despite high rates of hyperglycemia and DKA, only about half of patients with type 1 diabetes and COVID-19 required hospitalization, according to data from the T1D Exchange; mortality was low.
News
10% with diabetes hospitalized for COVID-19 die within a week
June 1, 2020
“Even in diabetes, each increase in BMI is associated with an increase in the risk of intubation and/or death in the 7 days following admission for COVID-19.”
News
‘The story unfolding is worrisome’ for diabetes and COVID-19
May 28, 2020
Diabetes Care has published a host of new articles on diabetes and COVID-19 infection, as NIDDK researchers also acknowledge risks to other organ systems from the SARS-CoV-2 virus.
